コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 asminogen activator inhibitor-1 antigen, and serum uric acid.
2 9 (SLC2A9), polymorphisms with variation in serum uric acid.
3 biased approach to identify loci influencing serum uric acid.
4 ations accounted for 4.3% of the variance of serum uric acid.
5 ut not meat had the lowest concentrations of serum uric acid.
6 d as the covariate responsible for rendering serum uric acid a statistically nonsignificant predictor
7 found positive genetic correlations between serum uric acid and BMI z score (rhoG = 0.45, P = 0.002)
8 nd specific association between the level of serum uric acid and cardiovascular morbidity and mortali
10 enous blood was taken for the measurement of serum uric acid and glycosylated haemoglobin (HbA1C).
11 In addition, genetic correlations between serum uric acid and other cardiovascular risk factors, s
12 ), 3000-m running time, serum triglycerides, serum uric acid and waist circumference (WC) were correl
13 mechanism for SLC2A9-mediated modulation of serum uric acid, and detail a bioinformatic approach for
14 ne of serum urea nitrogen, serum creatinine, serum uric acid, and serum phosphorus; and faster rate o
17 t actions exert a meaningful effect to lower serum uric acid by ~0.6 to 1.5 mg/dL and to reduce the r
18 model experiments demonstrate that increased serum uric acid causes increased BP that initially is re
20 ent an opinion on the nature of link between serum uric acid concentration and the risk for cardiovas
21 of causality arguments, one can start using serum uric acid concentration as an inexpensive cardiova
22 to test our hypothesis that the reduction in serum uric acid concentration induced by sevelamer would
23 cificity, 0.99; LR, 13 [95% CI, 3.1-53]) and serum uric acid concentration of 5.5 mg/dL or lower (sen
24 lopurinol intolerance or refractoriness, and serum uric acid concentration of 8.0 mg/dL or greater.
25 c uricase activity, leading to uniquely high serum uric acid concentrations (200-500 microM) compared
26 this study was to investigate differences in serum uric acid concentrations between meat eaters, fish
29 netic variation in SLC2A9 is associated with serum uric acid concentrations, an important biomarker o
30 A9, that explain 1.7-5.3% of the variance in serum uric acid concentrations, following a genome-wide
31 nsporters and their strong associations with serum uric acid concentrations, GLUT9 and ABCG2 appeared
34 ut and primates have uniquely high levels of serum uric acid due to missense mutations in the uricase
35 xcessive dietary sodium intake and increased serum uric acid during follow-up despite pharmacological
36 xcretion, the relationship between change in serum uric acid during follow-up, final left ventricular
37 systolic blood pressure, sodium intake, and serum uric acid emerged as independent and significant d
38 f single nucleotide polymorphisms (SNPs) and serum uric acid explain a small fraction of the heritabi
45 oring quantitative trait loci that influence serum uric acid in Mexican Americans using data from 644
46 er showed significantly higher level of mean serum uric acid in no diabetic retinopathy group (p = 0.
49 lowup provide evidence that higher levels of serum uric acid increase the risk of gout in a graded ma
50 ial hypertension, the prevalence of elevated serum uric acid is >90%, and preliminary clinical trial
51 nderance of data support the hypothesis that serum uric acid is a cause or exacerbating factor of hyp
56 aim was to investigate whether variation in serum uric acid is under genetic influence and whether t
58 atios for incident hyperuricemia (defined as serum uric acid level >/=7.0 mg/dL) according to prespec
59 was associated with a 0.24-mg/dL increase in serum uric acid level (P = 1.37 x 10(-80)) and a 1.75-fo
60 her the mechanism of association of elevated serum uric acid level (SUA) with cardiovascular disease
62 ol fractions, and plasma glucose levels, the serum uric acid level continued to predict the risk of d
63 l protein intake was not associated with the serum uric acid level in multivariate analyses (P = 0.74
65 ney function and cohort; therefore, elevated serum uric acid level is a modest, independent risk fact
68 rt at least once every other day had a lower serum uric acid level than did those who did not consume
69 med milk 1 or more times per day had a lower serum uric acid level than did those who did not drink m
70 in children, presenting the possibility for serum uric acid level to serve as a biomarker for diagno
71 nce was 1664+/-81 dyne x s x cm(-5), average serum uric acid level was 7.5+/-0.35 mg/dL, and average
72 In men, after adjustment for age, elevated serum uric acid level was not associated with increased
73 Among patients with chronic gout, elevated serum uric acid level, and allopurinol intolerance or re
75 ds have long been suspected of affecting the serum uric acid level, but few data are available to sup
76 d kidneys, reduced oxidative stress, lowered serum uric acid level, reduced glomerular hyperfiltratio
82 ft ventricular ejection fraction </=40%, and serum uric acid levels >/=9.5 mg/dL to receive allopurin
84 Rs2231142 was significantly associated with serum uric acid levels (P = 2.37 x 10(-67), P = 3.98 x 1
85 cebo and the allopurinol groups had baseline serum uric acid levels (SDs) of 8.7 (1.6) mg/dl and 8.3
86 (ABCG2) has been shown to be associated with serum uric acid levels and gout in Asians, Europeans, an
88 ent data on lifestyle factors that influence serum uric acid levels and the risk of gout and attempts
89 sweetened soda and orange juice can increase serum uric acid levels and, thus, the risk of gout, but
90 ogical studies have suggested that increased serum uric acid levels are a risk factor for cardiovascu
92 from the breakdown of purines, and elevated serum uric acid levels are associated with higher risk o
96 After adjusting for age, the difference in serum uric acid levels as compared with no intake increa
99 tudy was to evaluate the prognostic value of serum uric acid levels in a large cohort of men and wome
100 the relationship between dietary factors and serum uric acid levels in a nationally representative sa
101 , allopurinol effectively and safely lowered serum uric acid levels in adults with stage 3 CKD and as
103 Pegloticase is an enzyme used to reduce serum uric acid levels in patients with chronic, treatme
107 or women per 1,000 person-years according to serum uric acid levels of <5.0, 5.0-5.9, 6.0-6.9, 7.0-7.
109 n Survey suggested that these factors affect serum uric acid levels parallel to the direction of risk
110 effect of individual alcoholic beverages on serum uric acid levels varies substantially: beer confer
114 disease in both men and women increased when serum uric acid levels were in the highest quartile comp
115 ight heart catheterization was performed and serum uric acid levels were measured in all patients.
118 umans which is characterized by elevation in serum uric acid levels, and deposition of uric acid crys
119 athologies, including myocardial infarction, serum uric acid levels, mean platelet volume, aortic roo
129 lood cell count, blood glucose, D-dimer, and serum uric acid levels; and were more likely to have met
130 ral lines of evidence suggest that increased serum uric acid may be a significant modifiable risk fac
131 ial evidence suggests that agents that lower serum uric acid may lower BP in this select population.
133 From episodic, longitudinal sequences of serum uric acid measurements in 4368 individuals we prod
134 e lowest to the highest quartile of baseline serum uric acid, net mean changes (95% confidence interv
135 .37; 95% CI 1.06, 1.76; p = 0.015), elevated serum uric acid (OR 3.55; 95% CI 1.03, 12.27; p = 0.045)
136 -6.15, p < 0.001), hyperuricemia (per 1mg/dl serum uric acid; OR = 1.35, 95% CI = 1.12-1.62, p < 0.01
139 s negatively related to blood urea nitrogen, serum uric acid, proteinuria, and supernatant IL-4; wher
140 pharmacologic and nonpharmacologic means of serum uric acid reduction prior to clinical use as a the
141 gh the investigations are still preliminary, serum uric acid represents a possible new and intriguing
142 moking status, body mass index, haemoglobin, serum uric acid, serum albumin, albuminuria, and C react
144 Compared with placebo, allopurinol lowered serum uric acid significantly but did not improve endoth
146 ers of endothelial dysfunction, specifically serum uric acid (SUA) and urine albumin excretion (UAE),
151 s of SLC2A9/GLUT9 were associated with lower serum uric acid (SUA) levels and the effects were strong
155 atients initiating treatment for an elevated serum uric acid (SUA), the SUA normalized or improved in
156 500 mg/day of vitamin C for 2 months reduces serum uric acid, suggesting that vitamin C might be bene
164 ; CB: 159.4 ng/mL; P = 0.028), and increased serum uric acid (WA: 341.4 mumol/L; CB: 330 mumol/L; P =
173 , it is not known whether the association of serum uric acid with SLC2A9 polymorphisms manifests in c
174 t mean changes (95% confidence intervals) in serum uric acid with vitamin C supplementation were -0.4